In pulmonary hypertension, Gal-3 activates the AKT signaling pathway to overactivate pulmonary vascular adventitial fibroblasts, promoting the occurrence and development of PAH (pulmonary arterial hypertension) (Barman et al., 2019). The gene discussed is LGALS3; the disease is pulmonary hypertension.